A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volunteers

NCT06840769 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

50

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision

Conditions

Healthy Volunteers

Interventions

DRUG: Fosnetupitant 235 mg solution
DRUG: Akynzeo solution

Sponsor

Helsinn Healthcare SA